Company Milestone! Lexaid Completes Million-Level Financing, Injecting New Momentum into Cross-Border Healthcare

Lexaid (乐小助 / Lexiaozhu)—the cross-border medical companion brand of Shanghai Qile Wuyou Technology Co., Ltd. (上海其乐无忧科技有限公司)—has announced the successful closing of its angel round financing, raising several million RMB. The capital will support deeper hospital pathway matching, stronger multilingual companion teams, and continued expansion of overseas patient channels.

Aligned with growing global interest in high-quality care in China, Lexaid focuses on non-clinical coordination: specialty fit before travel, transparent communication, priority scheduling support with partner hospitals, and practical companionship through admission, treatment, and discharge. Clinical care remains with licensed clinicians at partner hospitals; Lexaid keeps the journey clear, multilingual, and organized.

The platform’s service scope covers pathways commonly sought by international families—complex specialty referrals, oncology-related coordination, chronic-care support, surgery logistics, and preventive health screening—delivered as a connected companion chain from first inquiry to departure.

Where the funding will go

• Medical pathway expansion — deepen collaboration with leading Class-A tertiary hospitals and specialty centers so matching stays precise and intake materials are clearer before patients fly.
• Service system upgrades — grow multilingual companion capacity and improve digital consultation workflows, from first inquiry through post-visit follow-up coordination.
• Overseas market development — strengthen localized partnerships across key patient-source regions and broaden referral collaboration with overseas healthcare and travel partners.

Ms. Suky Ji (及淑芳), Founder of Lexaid, said: “With this financing, we remain firmly committed to compliance-driven, non-clinical medical coordination. We respect China’s medical regulations and international privacy expectations. Our goal is to reduce information friction between domestic and international care journeys—and make Lexaid a trusted companion for patients who want high-quality, clear, and seamless access to care in China.”

Looking ahead, Lexaid will continue centering clinical excellence at partner hospitals and patient-centered companionship—building practical infrastructure for cross-border medical travel and helping China’s leading medical resources serve families worldwide.

Consultation: WhatsApp +86 185 2131 5346 · Email [email protected]
Learn more: www.lexaidmed.com